AI-driven drug discovery and synthesis

Targeting protein misfolding in neurodegenerative diseases using CRISPR-based chaperone systems

protein aggregation CRISPR-Cas9 molecular chaperones neurodegeneration gene therapy

Leveraging photoredox chemistry for selective C-H bond activation in pharmaceutical synthesis

photoredox catalysis C-H activation pharmaceutical synthesis organic chemistry visible-light

Predicting antibiotic resistance evolution using reaction prediction transformers in microbial genomics

antibiotic resistance transformer models microbial evolution drug development computational biology

Optimizing protein folding intermediates via quantum annealing methods for faster drug discovery

quantum annealing protein folding drug discovery intermediates computational biology

Yoctogram mass measurement methods for viral vector engineering precision

yoctogram measurement viral vectors gene therapy nanoscale sensors mass spectrometry

Using computational retrosynthesis to accelerate drug discovery from patent-expired natural compounds

computational retrosynthesis drug discovery natural compounds AI pharmaceuticals

For senolytic drug discovery using CRISPR-based senescence screening

senolytic drugs CRISPR screening cellular senescence aging research drug discovery

Marrying psychedelic research with neural decoding to map subjective experiences

psychedelic research neural decoding subjective experience brain imaging consciousness studies

Predicting rare chemical reaction pathways using reaction prediction transformers

machine learning retrosynthesis cheminformatics catalyst design reaction space

Accelerating drug discovery via quantum annealing methods for molecular modeling

quantum annealing drug discovery molecular modeling computational chemistry optimization algorithms

Using computational retrosynthesis for accelerated discovery of sustainable pharmaceuticals

computational chemistry green pharmaceuticals retrosynthesis algorithms drug discovery sustainability

For epigenetic age reversal via targeted CRISPR-Cas9 modulation of senescence-associated pathways

epigenetic reversal CRISPR-Cas9 senescence pathways age-related diseases gene editing